Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Product Details Semaglutide OL 12.5mg 2.5mg/ml x 5ml Manufacturer: Olympia Pharmaceuticals MFG#: C21691 PID: 639310 Beyond Use Date (BUD): 10/05/2025 Additional Information Description Semaglutide OL 12.5 mg (2.5 mg/mL 5 mL) is a glucagon-like peptide-1 (GLP-1) receptor agonist used primarily for the management of type 2 diabetes mellitus and chronic weight management
When it comes to formulation, look for powders or drinks that have sodium (100-500mg), potassium (1,600-3,500mg), and magnesium (300-420mg)
The most frequently reported adverse effects are gastrointestinal in nature , particularly when starting treatment
Clinical trial context: According to the manufacturer, the OASIS 4 trial showed approximately 13-14% average weight loss over 64 weeks, with higher results (up to 16.6%) reported among participants who adhered closely to the treatment protocol
That matters for interpretation, since the post's blood pressure numbers come from cardiovascular outcome trials in diabetes populations rather than from weight-management trials
00014-3/asset/416915f8-7d8e-4d73-b09f-ed12ab1bc489/main.assets/gr2.jpg)
